Click here for the article posted by Lisa Nainggolan on Medscape.
FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes
Grunberger Diabetes Institute Diabetes, Diabetes Medications FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes
Categories:
1 thought on “FDA OKs Dapagliflozin to Reduce HF Hospitalization in Diabetes”
Comments are closed.
Related Posts
Diabetes and Endocrinology and Public Health
Dr. George Grunberger of Grunberger Diabetes Institute had the honor of presenting Friday May 28th
What to Know About Zegalogue: A new glucagon rescue
Patients whose diabetes treatment includes insulin will experience hypoglycemic episodes, which occur when most people’s
How to Diagnose a Thyroid Condition
January is Thyroid Awareness Month, so it is only fitting we release an article with
Wonderful post! We are linking to this great post on our site. Leanna Martie Ulrika